WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of XJGVXQDUIWGIRW-UHFFFAOYSA-N.svg
isomerdesign

Loxapine

Vérifier sur isomerdesign

pubchem

Loxapine

Vérifier sur pubchem

drugmap

Loxapine

Vérifier sur drugmap

wiki

Loxapine

Vérifier sur wiki

Data

InChI: InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3

Synonymes: DB00408,2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine,Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-,2-Chloro-11-(4-methylpiperazino)dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine,LOXAPINE [VANDF],NCGC00021145-01,13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene,Loxapina [INN-Spanish],8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine,Lossapina,BSPBio_003479, 2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine,LOXAPINE [USAN],SCHEMBL94146,Adasuve (TN),LOXAPINE [INN],NCGC00022279-05,Loxitane,NCGC00021145-23,13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaene, Loxepine,NCGC00022279-04,LER583670J,Loxapinum,Adasuve,CL71,563,s5197,Staccato loxapine,L001085,2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine,Lopac0_000720,CL 62,362, Loxitane IM,BSPBio_000204,Prestwick0_000132,HF 3170,GTPL205,8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine,EINECS 217-835-3,SpecPlus_000823, 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine, Loxapinum [INN-Latin],Loxitane Intramuscular,977L102, 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine,SDCCGSBI-0050698.P003,KBio3_002983, SUM 3170,Spectrum5_001857, CL-71,563,BRD-K39915878-036-15-2,loxapine, CL 62362,LOXAPINE [MI],Hydrofluoride 3170,NCGC00021145-02,CL-62362, Lossapina,Oxilapine,KBio2_005971, Loxapina [INN-Spanish],HSDB 3111,13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene,C07104,Loxapine (DMSO), Lossapina [DCIT],S-805,Prestwick3_000132, Loxapine [USAN:INN:BAN],KBioSS_000835,Spectrum3_001830,Dibenzacepin,CS-1105,8-chloro-6-(4-methylpiperazino)benzo[b][1,4]benzoxazepine;succinic acid,CCG-204805,S 805,KBio2_000835,NCGC00021145-04,2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine, Loxapina,PDSP1_001058, Oxilapine,LW 3170,Q58614,AZ-004, Loxapine (USAN/INN),BPBio1_000226, Loxapinsuccinate,DTXSID7023229,BDBM22871,Loxapin,DivK1c_006919, Dibenzoazepine,HY-17390,EN300-6479125,Loxitane-C Oral Suspension,AB00053735_16,BRD-K39915878-036-04-6,Prestwick1_000132,SUM-3170,AB00053735_15,Lossapina [DCIT], Dibenzacepin,QTL1_000050,BRD-K39915878-036-05-3,NCGC00021145-05, HF 3170,Spectrum2_001737,LOXAPINE [ORANGE BOOK],Prestwick2_000132,D02340, 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine,UNII-LER583670J,Loxapine (USAN/INN),NCGC00021145-06,CL 62362,SPBio_002143,ZINC19796158,Loxapina,KBio1_001863,NCGC00022279-03,LOXAPINE [HSDB],Loxapine,1977-10-2,SPBio_001814,CHEBI:50841,Spectrum_000355, Loxapin,CHEMBL831,2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine, Hydrofluoride 3170,LOXAPINE [WHO-DD],NCGC00021145-03,SUM 3170,Loxapinum [INN-Latin],LOXAPINE [MART.], LW 3170, HF3170, Loxapine [USAN:BAN:INN],PDSP2_001042, CL-62362,HF3170,Loxapine [USAN:INN:BAN],BRN 0626753, 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine, Loxitane (TN),NCGC00021145-07,Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-,Cloxazepine, S 805,NCGC00021145-08, Loxapinum,Loxapine (water), S-805, Loxapac (TN),Dibenzoazepine,KBio2_003403


Estimated data

Solubility: -3.55 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 28.2% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.